of Baht 638.12 million, a 22.02% improvement year-over-year from Baht 522.98 million in 2017. This was mostly due to an increase in revenues from Inpatients, Outpatients and opening of IVF Center. The

year 2018 are Baht 127.9 million, an increase of Baht 68.5 million or 115%, mainly resulted from impairment loss from leasehold right of land and building improvement due following to the termination

from last year at 12.55% as the company implemented better production cost control for new products that could cause an improvement in production efficiency and could reduce loss in many as aspects. 3

reported Revenues from hospital operations of Thai Baht 886.04 million, a 38.85% improvement year-over-year from Baht 638.12 million in 2018. This was mostly due to an increase in revenues from Inpatients

% of net profit margin comparing with Q2 2016. Apart from the additional costs of SBT’s impairment, the increment of gross and net profit was mostly caused by the improvement of products’ spread margin

machines, as well as the decrease in production cost while there is no significant increase in other expenses. Overall, it resulted in the improvement of net profit margin for the group as mentioned. Please

MTHB or 4.8% of net profit margin comparing with Q3 2016. Apart from the additional costs of SBT’s liquidation, the increment of gross and net profit was mostly caused by the improvement of products

55.98% and 56.10% respectively which is resulting from the proper management of manpower at stores and back office including the better results from the process improvement project and more staff training

issued in July 2017. Compared to the preceding quarter, 3Q17 revenues grew by 4% with an improvement in net earnings of 12%, mainly attributed to higher contribution from NVD, lower SG&A expenses and

. Meanwhile, net plant and equipment increased by Baht 49.62 million from building under construction at Chonburi branch to support business expansion and investment for production line improvement of spray